2017
DOI: 10.1177/0194599816632178
|View full text |Cite
|
Sign up to set email alerts
|

Panel 6: Vaccines

Abstract: Objective To review the literature on progress regarding (1) effectiveness of vaccines for prevention of otitis media (OM) and (2) development of vaccine antigens for OM bacterial and viral pathogens. Data Sources PubMed database of the National Library of Science. Review Methods We performed literature searches in PubMed for OM pathogens and candidate vaccine antigens, and we restricted the searches to articles in English that were published between July 2011 and June 2015. Panel members reviewed literatu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 119 publications
0
11
0
Order By: Relevance
“…The mechanism of this effect is not understood and all children in Nepal receive Vitamin A. The second intervention that has been shown to possibly reduce CSOM is pneumococcal immunisation which continues to be evaluated, with current reductions in acute otitis media of 6 to 43% reported from developed nations [28]. In addition, successful clinical treatment programs such as the Earbus in Western Australia report significant reductions in CSOM but need community engagement, skilled staff and intensive follow-up which is difficult to achieve in low resource settings such as Jumla [29].…”
Section: Discussionmentioning
confidence: 99%
“…The mechanism of this effect is not understood and all children in Nepal receive Vitamin A. The second intervention that has been shown to possibly reduce CSOM is pneumococcal immunisation which continues to be evaluated, with current reductions in acute otitis media of 6 to 43% reported from developed nations [28]. In addition, successful clinical treatment programs such as the Earbus in Western Australia report significant reductions in CSOM but need community engagement, skilled staff and intensive follow-up which is difficult to achieve in low resource settings such as Jumla [29].…”
Section: Discussionmentioning
confidence: 99%
“…Moraxella catarrhalis is a human respiratory tract pathogen that is often carried asymptomatically in the nasopharynx [1], but frequently causes otitis media (OM) in infants and children, and exacerbations of chronic obstructive pulmonary disease (COPD) in adults. Along with Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi), M. catarrhalis is among the most prevalent bacterial causes of OM where it is detected by PCR in up to 56% of middle ear fluid associated with OM [2]. M. catarrhalis also causes approximately ~ 10% of exacerbations of COPD each year in the USA [3].…”
Section: Introductionmentioning
confidence: 99%
“…The introduction of the pneumococcal conjugate vaccination (PCV) in the pediatric population has led to an important reduction of OM episodes caused by the serotypes included in the vaccine [46]. On the other hand, the introduction of pneumococcal vaccination programs has resulted in important modifications in OM microbiology: H. influenzae has become the most common otopathogen and OM episodes caused by M. catarrhalis have become more frequent; moreover, serotypes not included in PCVs have been more frequently identified as causative agents of diseases [47,48].…”
Section: Pneumococcal Vaccinationmentioning
confidence: 99%